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Xi-Ling Wang1, Chit-Ming Wong1,5*, Kwok-Hung Chan2, King-Pan Chan1, Pei-Hua Cao1, JS Malik Peiris1,3
and Lin Yang1,4Abstract
Background: Reliable assessment for the severity of the 2009 H1N1 pandemic influenza is critical for evaluation of
vaccination strategies for future pandemics. This study aims to estimate the age-specific hospitalization risks of the
2009 pandemic cases during the first wave in Hong Kong, by combining the findings from the serology and disease
burden studies.
Methods: Excess hospitalization rates associated with the pandemic H1N1 were estimated from Poisson regression
models fitted to weekly total numbers of non-accidental hospitalization from 2005 to 2010. Age-specific
infection-hospitalization risks were calculated as excess hospitalization rates divided by the attack rates in the
corresponding age group, which were estimated from serology studies previously conducted in Hong Kong.
Results: Excess hospitalization rate associated with pandemic H1N1 was highest in the 0–4 age group (881.3 per
100,000 population), followed by the 5–14, 60+, 15–29, 50–59, 30–39 and 40–49 age groups. The hospitalization risk
of the infected cases (i.e. infection-hospitalization risk) was found highest in the 60+ age group and lowest in the
15–29 age group, with the estimates of 17.5% and 0.7%, respectively.
Conclusions: People aged 60 or over had a relatively high infection-hospitalization risk during the first wave of the
2009 H1N1 pandemic, despite of a low attack rate in this age group. The findings support the policy of listing older
people as the priority group for pandemic vaccination.
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The 2009 influenza pandemic caused by a novel swine-
origin influenza A/H1N1 virus (A(H1N1)pdm09) was
the first pandemic in the twenty-first century. Proper
assessment for the severity of the 2009 H1N1 pan-
demic is critical for evaluation of vaccination strategies
for future pandemics. Hospitalization risk of the infected
cases, termed as “infection-hospitalization risk (IHR)”
hereafter, is a key indicator for the severity of infectious
diseases [1]. However obtaining a reliable estimate for IHR
remains challenging, because infected cases might have not
shown any symptoms or not been differentiated from other
respiratory infections. Another challenge lies in a variety of* Correspondence: hrmrwcm@hku.hk
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stated.numerators and denominators used for IHR calculation.
Symptomatic infection-hospitalization risk (sIHR), which
used the number of cases with influenza-like illness (ILI)
as denominator and hospitalized cases with laboratory-
confirmed A(H1N1)pdm09 as numerator, was quickly
calculated at the early stage of the pandemic to allow
timely medical resource allocation for the containment [2].
But sIHR could be a biased indicator, as not all the ILI cases
were infected with A(H1N1)pdm09. Confirmed infection-
hospitalization risk (cIHR) was later calculated as the
number of hospitalized cases with laboratory-confirmed A
(H1N1)pdm09 divided by the number of A(H1N1)pdm09
cases estimated from the serological studies on the sero-
conversion rates of A(H1N1)pdm09 antibodies among
the general population [3-5]. The denominator of cIHR
was able to capture asymptomatic and mild infections who
did not seek medical treatment. However, the numerator
of cIHR probably underestimated the true numbers oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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hospitalized cases were tested in a timely manner and
some were tested negative due to waning virus titers when
admitted into hospital several days after the onset of illness.
To obtain reliable estimates of A(H1N1)pdm09-associated
hospitalization, we conducted a study to calculate A(H1N1)
pdm09-associated excess hospitalization, using a statistical
model that has been widely applied in estimating disease
burden of influenza. Model derived excess hospitalization
is believed to capture both laboratory confirmed influenza
hospitalized cases and those who were not laboratory
diagnosed [6]. We then used this estimate of A(H1N1)
pdm09-associated excess hospitalization as the numer-
ator and the estimate of A(H1N1)pdm09 infected cases
from the previous serological studies as the denominator
[4,5], to calculate the infection-excess hospitalization risk
(eIHR) of the 2009 H1N1 pandemic in Hong Kong.
Methods
Data
Hospitalization records from 2005 to 2010 in Hong Kong
were obtained from the electronic database of the Hospital
Authority, which manages 41 public hospitals covering
78% of total hospital bed-days in the whole territory
[7]. These hospitalization data recorded up to 15 discharge
diagnoses for each hospitalized patient, but were not linked
to any baseline characteristics of lifestyle factors and
co-morbidities nor specific medical treatments received
by these patients. Weekly numbers of non-accidental
hospitalization were aggregated for the age groups of 0–4,
5–14, 15–29, 30–39, 40–49, 50–59 and 60 or over (60+)
years by excluding the cases with any of the 15 listed
discharge diagnosis of accidental cause (International
Classification of Diseases version 9 codes (ICD9), 001–799).
Age-stratified laboratory-confirmed hospitalization with
A(H1N1)pdm09 infection during the first wave pandemic
(26 April 2009 to 2 January 2010) were obtained from the
eFlu database managed by the Hospital Authority, which
collected the demographic data as well as hospitalization
and fatal outcomes of laboratory-confirmed A(H1N1)
pdm09 cases in Hong Kong [5].
Influenza virus surveillance data were obtained from
the microbiology laboratory of the Queen Mary Hospital,
which is one of the largest public hospitals in Hong Kong.
Nasopharyngeal specimens were collected from the patients
with influenza-like symptoms and tested for influenza
(type A and B), respiratory syncytial virus (RSV), adeno-
virus and parainfluenza viruses by immunofluorescence
tests [8]. Nearly 90% of influenza A positive specimens were
further subtyped into seasonal A(H1N1) and A(H3N2) by
viral culture and haemagglutination inhibition tests. During
the 2009 pandemic, the specimens were also tested for A
(H1N1)pdm09 by RT-PCR. This laboratory tested all the
virus samples collected in Hong Kong Island and providedmore than 20% of specimens to the Department of Health
virology surveillance network from 2005 to 2010. Our pre-
vious study has demonstrated that the virology data of this
single laboratory were able to represent the virus activity in
the entire Hong Kong [9]. The virology data were then
aggregated into weekly age-specific numbers of posi-
tive specimens for each virus. Meteorological data of
temperature and relative humidity were obtained from
the Hong Kong Observatory.
Statistical analysis
Poisson regression models were fitted to weekly num-
bers of non-accidental hospitalization for the age groups
of 0–4, 5–14, 15–29, 30–39, 40–49, 50–59 and 60 or
over (60+) years, with the influenza proxy variables of
weekly age-specific numbers of positive specimens for
A(H1N1), A(H3N2), B and A(H1N1)pdm09 simultaneously
entered. Confounding was adjusted for by adding weekly
age-specific positive isolate numbers of other respiratory
viruses (RSV, adenovirus and parainfluenza), long term
and seasonal trends, temperature and relative humidity, as
previously described [10]. Baseline hospitalization was
estimated by setting the proxy variable of A(H1N1)
pdm09 to zero in the Poisson model under the assump-
tion of no A(H1N1)pdm09 circulating. Age-specific excess
hospitalization was then derived as the difference be-
tween the fitted and baseline hospitalization during the
first pandemic wave of 26 April 2009 to 2 January
2010. Excess hospitalization rate was calculated by div-
iding excess hospitalization with age-specific annual
population size, which was estimated from the census
data by linear interpolation.
Age-specific eIHR was calculated with the age-specific
excess hospitalization rate as numerator and the correspond-
ing attack rate estimated from two local serological studies
as denominator (eIHR ¼ Excess hospitalization rateAttack rate ) [4,5]. cIHR
had a similar formula, in that the numerator was switched
to laboratory confirmed A(H1N1)pdm09 hospitalization
which was reported by the eFlu database of Hospital
Authority (cIHR ¼ Laboratory confirmed hospitalization rateAttack rate ). Because
the age-specific attack rate was only available for the
first wave of the 2009 pandemic, we calculated the eIHR
and cIHR only for this period. Also the attack rate of A
(H1N1)pdm09 in young children aged below 5 years
was not available in these serological studies; therefore
we were unable to provide estimates for the 0–4 and
all-ages groups. The 95% confidence interval of eIHR
was calculated using the Delta method.
Sensitivity analysis
Respiratory and circulatory diseases were considered as
more specific outcomes to influenza infection than non-
accidental hospitalization, although previous studies have
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diseases (such as diabetes, renal diseases and cancers) also
had higher risk of hospitalization and mortality associated
with influenza [11,12]. Nevertheless, to test for the robust-
ness of our models, we conducted a sensitivity analysis by
replacing the outcome of non-accidental hospitalization
with the more specific health outcome of respiratory and
circulatory hospitalization. Similar to our main analysis,
Poisson regression models were fitted to weekly numbers
of respiratory and circulatory hospitalization for seven age
groups, respectively.
The ethical approval for this study was obtained from
the Institutional Review Board of the University of
Hong Kong/Hospital Authority Hong Kong West Cluster
(UV11-264). All analyses were conducted in the R package
(version 2.14.2).
Results
Weekly observed and fitted non-accidental hospitalization
number was shown in Figure 1. Significant association
of A(H1N1)pdm09 with hospitalization was only found
in the age groups below 30 years old (p < 0.05). According
to our point estimate, during the first wave of the 2009
H1N1 pandemic, there were a total of 10,178 excess
hospitalization associated with A(H1N1)pdm09, which
was markedly higher than the total number of 7,386
laboratory-confirmed cases who were hospitalized and re-
ported by the eFlu database. Excess rate of hospitalization
associated with A(H1N1)pdm09 was highest in the 0–4
age group (881.3 per 100,000 population), followed by the
5–14, 60+, 15–29, 50–59, 30–39 and 40–49 age groups
(Table 1). The estimated excess rates were comparable to
the rates of laboratory confirmed hospitalization in chil-
dren and young adults, but one to three times higher for
the age groups of 50–59 and 60+. The eIHR were found
highest in the 60+ age group and lowest in the 15–29
age group, with the estimates of 17.5% (95% confidence
interval −64.4%, 99.4%) and 0.7% (0.2%, 1.2%), respect-
ively. eIHR ranged from 0.9% to 1.6% in the rest of age
groups (Table 1).
The sensitivity analysis showed that A(H1N1)pdm09-
associated hospitalization for respiratory and circulatory
diseases accounted for 65-89% of those for non-
accidental hospitalization in all the age groups, with an
age pattern similar to the non-accidental hospitalization
(data not shown).
Discussion
Our study applied the Poisson regression model rather
than the Serfling approach to estimate the influenza-
associated hospitalization in Hong Kong. The Serfling
approach requires a clear seasonality of influenza virus
activity to define non-epidemic and epidemic period
[13]. However, this prerequisite cannot be satisfied insubtropical and tropical regions like Hong Kong, where
seasonality of influenza is less clear and influenza virus
circulates throughout the year [14]. Moreover, it is diffi-
cult to separate the effects of multiple respiratory viruses
using the Serfling approach as the seasonal peaks of
many viruses tended to overlap with each other. On the
contrary, the Poisson regression model does not require
a clear seasonal pattern of influenza, thus it is especially
useful for tropical and subtropical regions [14]. In the
Poisson regression model, we used the age-specific posi-
tive number as a proxy for the activity of each virus.
During the pandemic, the laboratory practice could be
biased towards children and young adults as they were
more likely to be tested, so the all-ages positive number
might be a biased indicator for virus activity. The use of
age-specific positive number ensured that the changes in
laboratory practice between age groups would not affect
our age-specific results. Our models were partly validated
by comparing the model estimates with the laboratory-
confirmed cases of A(H1N1)pdm09 infections, which
was reported by the electronic reporting system eFlu
managed by the Hospitalization Authority. These reported
numbers could be regarded as the lower boundary of the
hospitalization burden caused by the pandemic. Our model
estimates were all above these lower bounds, suggesting
that our estimates were valid.
The cumulative incidence of A(H1N1)pdm09 from
serologic study revealed high attack rates in children and
adolescents, with almost half (43.5%) of school age chil-
dren infected during the first wave of the 2009 H1N1
pandemic. However the attack rate in the older popula-
tion was much lower, with only 0.8% of people aged 60
or over infected. This pattern of attack rates was consist-
ent with findings from a British serologic survey [3]. The
different attack rates across age groups could be prob-
ably due to their prior exposure to antigenically similar
influenza viruses [15]. Here we used serological attack
rates as the denominator of IHR, which could provide a
better assessment for morbidity risk after infection than
one using influenza-like-illness incidence as the denom-
inator, as the former could include asymptomatic infec-
tions and minimize the ascertainment bias.
Early sIHR estimates in the US showed a higher
hospitalization risk in the 0–4 age group than the other
age groups [2]. The estimates of all-ages sIHR or cIHR
later reported a range from 0.14% to 1% [16,17]. Our
findings of higher eIHR in the 50–59 and 60+ age
groups echoed a study in Netherlands, although their
estimates of cIHR were markedly lower than ours [18].
Higher hospitalization risks in Hong Kong could prob-
ably be explained by regional difference in health seek-
ing behavior and host immunity levels. Based on our
previous estimate of 127 deaths associated with the
pandemic influenza during the same period [9], the
Figure 1 Weekly observed (dots) and fitted (solid black line) numbers of hospitalization for non-accidental causes. Solid grey line
indicates the baseline when all the influenza proxies were assumed equal to zero.
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pandemic was around 1% in Hong Kong, suggesting a
relatively mild pandemic. At the beginning of the 2009
pandemic, the Hong Kong Special Administrative Region
government issued instant warnings and at the same
time quickly adopted a variety of nonpharmaceutical
control measures, such as school closure and border
control, in the whole territory [19]. Special influenza clinics
were soon open and laboratory tests were extensively
conducted, especially in children and young adults who
were immediately identified as high risk groups. The
close match of eIHR and cIHR point estimates, together
with the low mortality rate in all the age groups younger
than 50 years [9,12], suggests that these control measuresmight have effectively identified the infected cases and
successfully reduced casualties among young people.
Our eIHR estimates revealed a higher hospitalization
risk of A(H1N1)pdm09 cases in people aged over 60 years
than the other age groups. Previous studies have dem-
onstrated that during the first wave of the 2009 H1N1
pandemic, the attack rate of A(H1N1)pdm09 was lower in
adults aged over 60 years, probably due to their preexisting
antibodies against A(H1N1)pdm09 [20]. However, this
does not mean older people were fully exempted from the
severe complications caused by A(H1N1)pdm09 infec-
tions. Serious underreporting of A(H1N1)pdm09 cases in
Hong Kong elders under medical settings, as revealed by our
study [10] and also others, requires further investigations.
Table 1 Infection-hospitalization risks based on confirmed hospitalization (cIHR) and on excess hospitalization (eIHR)
during the first wave of the 2009 H1N1 pandemic
Age Population Infection
attack rate*
Confirmed Hospitalization cIHR Excess Hospitalization eIHR
% (95% CI) No. Rate
(per 100,000 population)
% (95% CI) No. Rate
(per 100,000 population)
% (95% CI)
0-4 234583 NA 1842 785.2 NA 2067 881.3 NA
5-14 635423 43.5 (39.6, 48.3) 2445 384.8 0.9 (0.8, 1.0) 2774 436.6 1.0 (0.0, 2.0)
15-29 1410126 16.9 (12.4, 21.3) 1313 93.1 0.6 (0.4, 0.8) 1650 117.0 0.7 (0.2, 1.2)
30-39 1118446 5.8 (3.1, 9.7) 470 42.0 0.7 (0.4, 1.4) 554 49.6 0.9 (−2.2, 3.9)
40-49 1267108 3.8 (1.1, 7.5) 375 29.6 0.8 (0.4, 2.7) 501 39.5 1.0 (−3.6, 5.7)
50-59 1073032 5.0 (2.4, 8.3) 495 46.1 0.9 (0.6, 1.9) 878 81.8 1.6 (−3.3, 6.5)
60+ 1249965 0.8 (0.2, 4.2) 446 35.7 4.5 (0.8, 17.8) 1754 140.3 17.5 (−64.4, 99.4)
Abbreviations: CI confidence interval, NA not available.
* Adapted from ref (4,5).
Wang et al. BMC Infectious Diseases 2014, 14:32 Page 5 of 6
http://www.biomedcentral.com/1471-2334/14/32This underreporting might be partly due to less typical
influenza-like symptoms after the A(H1N1)pdm09 in-
fections compared to younger adults [21], or chronic
conditions commonly occurred in older population.
Studies have found that the risk of hospitalization and
ICU admission after A(H1N1)pdm09 infections mark-
edly increased among people with chronic conditions
such as cardiovascular, respiratory and metabolic con-
ditions [22]. Our previous estimates on cause-specific
hospitalization associated with A(H1N1)pdm09 also
indicated that a large proportion of hospitalization oc-
curred in those with chronic conditions [10]. It is of note
that our point estimate of eIHR in the 60+ age group re-
quires cautious interpretation because of its wide confi-
dence intervals, probably due to the relative short period
of pandemic in the first wave. Nevertheless, it is surprising
that the eFlu surveillance system was able to capture
the majority of hospitalized pandemic cases younger
than 50, but only captured 30-60% hospitalized pan-
demic cases for those older than 50 years. The hidden
burden in older population of Hong Kong reveals a
need to enhance laboratory surveillance in this popula-
tion in future pandemic.
Whether vaccination priority shall be given to people
with high mortality/hospitalization risk or to those more
likely transmit the virus during the pandemic remains a
controversial issue. However, most health authorities
adopted the former vaccination strategy with the aim
to reduce casualty and severe outcomes. In Hong Kong,
the pandemic vaccines were not available until the end of
December 2009 and older people were immediately listed
as the priority group for pandemic vaccination despite of
the low attack rate in this age group during the pandemic.
Our findings of higher eIHR in older population well sup-
port the decision by the health authority of Hong Kong
and most of other countries [23,24]. However, if vaccines
could be ready at the early phase of future pandemics, thedecision on vaccination strategy should rely on quick and
accurate estimates on transmission, morbidity and mor-
tality burden in different age groups, in order to make
the optimal utilization of medical resources.
Conclusions
Our study found that during the first wave of the 2009
H1N1 pandemic, hospitalization risk of infected pandemic
cases was higher in old people than in young adults and
children. Old persons may require more medical resources
after infection of the pandemic influenza. The findings
support to include older people in the priority groups for
pandemic vaccination.
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